Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal
Open Access
- 28 July 2016
- journal article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 7 (1), 12326
- https://doi.org/10.1038/ncomms12326
Abstract
Cancer stem cells (CSCs) have key roles in treatment resistance, tumour metastasis and relapse. Using colorectal cancer (CC) cell lines, patient-derived xenograft (PDX) tissues and patient tissues, here we report that CC CSCs, which resist chemoradiation, have higher SUMO activating enzyme (E1) and global SUMOylation levels than non-CSCs. Knockdown of SUMO E1 or SUMO conjugating enzyme (E2) inhibits CC CSC maintenance and self-renewal, while overexpression of SUMO E1 or E2 increases CC cell stemness. We found that SUMOylation regulates CSCs through Oct-1, a transcription factor for aldehyde dehydrogenases (ALDHs). ALDH activity is not only a marker for CSCs but also important in CSC biology. SUMO does not modify Oct-1 directly, but regulates the expression of TRIM21 that enhances Oct-1 ubiquitination and, consequently, reducing Oct-1 stability. In summary, our findings suggest that SUMOylation could be a target to inhibit CSCs and ultimately to reduce treatment resistance, tumour metastasis and relapse.Keywords
This publication has 54 references indexed in Scilit:
- Characterization of the Loss of SUMO Pathway Function on Cancer Cells and Tumor ProliferationPLOS ONE, 2015
- Interferon controls SUMO availability via the Lin28 and let-7 axis to impede virus replicationNature Communications, 2014
- Lineage Tracing Reveals Lgr5 + Stem Cell Activity in Mouse Intestinal AdenomasScience, 2012
- A restricted cell population propagates glioblastoma growth after chemotherapyNature, 2012
- ALDH as a Marker for Enriching Tumorigenic Human Colonic Stem CellsMethods in Molecular Biology, 2012
- Differentiated Human Colorectal Cancer Cells Protect Tumor-Initiating Cells From IrinotecanGastroenterology, 2011
- ALDH1 as a Functional Marker of Cancer Stem and Progenitor CellsStem Cells and Development, 2009
- Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell PopulationsMolecular Cancer Research, 2008
- SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasomeMolecular Cancer Therapeutics, 2008
- Sumoylation is involved in beta-catenin-dependent activation of Tcf-4The EMBO Journal, 2003